March 20, 2008 Panel orders centralized pretrial proceedings in NSF cases Shalmali Pal -------------------------------------------------------------------------------- The discovery process for more than 60 federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents will be consolidated at a single district court in Ohio, according to a U.S. judicial panel. Centralization will accelerate the discovery process and give plaintiffs access to a wider pool of pretrial information. As of late February, 66 federal cases had been filed on behalf of patients with renal failure who allege that gadolinium-based contrast agents triggered NSF, a life-threatening skin condition. In early March, a California couple filed a suit in the U.S. District Court for the Northern District of California against several contrast agent developers.
![](https://storage.ning.com/topology/rest/1.0/file/get/396595535?profile=original)
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC
You need to be a member of radRounds Radiology Network to add comments!
Join radRounds Radiology Network